Ibuprofen
ibuprofen pharmacology mechanism of action dosing indications
ibuprofen adverse effects contraindications drug interactions
| Category | Examples |
|---|---|
| Pain | Headache, dental pain, musculoskeletal pain, dysmenorrhea, post-operative pain |
| Inflammation | Arthritis (OA, RA), gout, bursitis, tendinitis |
| Fever | Adults and children (>6 months) |
| Other | Pericarditis, patent ductus arteriosus (IV form in neonates) |
| Use | Adult Dose | Max Daily Dose |
|---|---|---|
| OTC analgesic/antipyretic | 200–400 mg every 4–6 h | 1,200 mg/day |
| Prescription (pain/inflammation) | 400–800 mg every 6–8 h | 3,200 mg/day |
| Pediatric (fever/pain) | 5–10 mg/kg every 6–8 h | 40 mg/kg/day |
| Drug | Interaction |
|---|---|
| Warfarin / anticoagulants | Increased bleeding risk |
| Aspirin (low-dose) | Ibuprofen can competitively block aspirin's irreversible COX-1 binding, reducing cardioprotective effect |
| ACE inhibitors / ARBs | Reduced antihypertensive effect; increased AKI risk ("triple whammy" with diuretics) |
| Diuretics | Reduced diuretic efficacy; risk of AKI |
| Lithium / Methotrexate | Reduced renal clearance → toxicity |
| SSRIs | Additive GI bleeding risk |
| Drug | COX selectivity | GI risk | Cardiovascular risk | Duration |
|---|---|---|---|---|
| Ibuprofen | Non-selective | Moderate | Lower than COX-2 inhibitors | Short-acting (4–8 h) |
| Naproxen | Non-selective | Moderate | Lowest among NSAIDs | Long-acting (8–12 h) |
| Celecoxib | COX-2 selective | Lower | Higher | 12–24 h |
| Aspirin | Non-selective (irreversible) | Higher | Protective at low dose | Variable |